ArticleCase reports in hematology2026

Excellent Response to Eculizumab in a Patient With Complement-Mediated Thrombotic Microangiopathy and a Novel Plasminogen Gene Variant.

Aman Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.